SEI Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.6M Sell
198,139
-6,318
-3% -$2.34M 0.07% 317
2026
Q1
$59.9M Buy
204,457
+25,631
+14% +$8.42M 0.06% 364
2025
Q4
$62.7M Buy
178,826
+7,268
+4% +$2.46M 0.06% 323
2025
Q3
$55.4M Buy
171,558
+7,890
+5% +$2.45M 0.06% 323
2025
Q2
$63.7M Buy
163,668
+9,758
+6% +$3.92M 0.07% 285
2025
Q1
$66.9M Buy
153,910
+4,333
+3% +$1.74M 0.09% 263
2024
Q4
$55.2M Buy
149,577
+18,858
+14% +$7.89M 0.07% 292
2024
Q3
$68M Buy
130,719
+6,847
+6% +$3.66M 0.09% 245
2024
Q2
$67.1M Buy
123,872
+11,513
+10% +$6.09M 0.1% 226
2024
Q1
$58.3M Buy
112,359
+5,145
+5% +$2.56M 0.09% 251
2023
Q4
$50.6M Sell
107,214
-305
-0.3% -$141K 0.08% 271
2023
Q3
$46.8M Sell
107,519
-31,222
-23% -$14.2M 0.08% 243
2023
Q2
$61.6M Buy
138,741
+12,707
+10% +$5.86M 0.11% 181
2023
Q1
$58M Buy
126,034
+24,362
+24% +$11.6M 0.11% 194
2022
Q4
$52.2M Sell
101,672
-12,724
-11% -$6.46M 0.12% 184
2022
Q3
$52M Buy
114,396
+9,315
+9% +$4.46M 0.12% 170
2022
Q2
$50.4M Buy
105,081
+16,488
+19% +$8.16M 0.11% 182
2022
Q1
$43.2M Sell
88,593
-1,863
-2% -$852K 0.09% 239
2021
Q4
$41.8M Sell
90,456
-1,445
-2% -$608K 0.08% 260
2021
Q3
$34.2M Sell
91,901
-17,930
-16% -$6.81M 0.07% 293
2021
Q2
$41.9M Buy
109,831
+8,841
+9% +$3.38M 0.09% 219
2021
Q1
$36.2M Buy
100,990
+37,064
+58% +$11.9M 0.09% 222
2020
Q4
$20.5M Buy
63,926
+9,165
+17% +$2.81M 0.05% 362
2020
Q3
$14.7M Buy
54,761
+2,721
+5% +$732K 0.04% 400
2020
Q2
$13.7M Sell
52,040
-2,323
-4% -$620K 0.04% 415
2020
Q1
$12.3M Sell
54,363
-239,924
-82% -$65.4M 0.05% 394
2019
Q4
$89.1M Sell
294,287
-18,517
-6% -$5.1M 0.27% 60
2019
Q3
$74.8M Sell
312,804
-55,614
-15% -$15.2M 0.19% 86
2019
Q2
$104M Buy
368,418
+11,392
+3% +$3.11M 0.34% 44
2019
Q1
$102M Sell
357,026
-94,833
-21% -$27.4M 0.34% 44
2018
Q4
$124M Sell
451,859
-1,413
-0.3% -$389K 0.44% 35
2018
Q3
$124M Buy
453,272
+25,419
+6% +$6.6M 0.45% 35
2018
Q2
$102M Buy
427,853
+392,889
+1,124% +$91M 0.35% 44
2018
Q1
$7.68M Sell
34,964
-251,711
-88% -$59.1M 0.03% 627
2017
Q4
$52.8M Buy
286,675
+13,712
+5% +$2.92M 0.18% 112
2017
Q3
$52M Sell
272,963
-68,756
-20% -$13.1M 0.18% 112
2017
Q2
$64.3M Sell
341,719
-9,422
-3% -$1.69M 0.26% 72
2017
Q1
$58.1M Buy
351,141
+32,829
+10% +$5.22M 0.25% 75
2016
Q4
$45.9M Buy
318,312
+7,057
+2% +$945K 0.22% 91
2016
Q3
$39M Buy
311,255
+2,040
+0.7% +$263K 0.2% 112
2016
Q2
$40.6M Buy
309,215
+31,635
+11% +$4.33M 0.24% 92
2016
Q1
$38.6M Buy
277,580
+59,669
+27% +$7.97M 0.24% 103
2015
Q4
$30.4M Buy
217,911
+57,785
+36% +$7.96M 0.19% 137
2015
Q3
$22.4M Buy
160,126
+90,762
+131% +$13.6M 0.21% 114
2015
Q2
$11.4M Sell
69,364
-5,136
-7% -$821K 0.1% 237
2015
Q1
$11.5M Sell
74,500
-11,817
-14% -$1.68M 0.1% 244
2014
Q4
$10.8M Buy
+86,317
New +$10.7M 0.1% 254

Other funds holding ELV

SEI Investments's ELV Position: Q2 2026 in Review

SEI Investments reduced its Elevance Health (ELV) stake by 3.1% in Q2 2026, selling an estimated $2.34M and leaving 198,139 shares worth $76.6M. The position accounts for 0.07% of the portfolio, ranked #317.

SEI Investments first reported a position in ELV in Q4 2014 and has held it in 47 quarters since. The position peaked at $124M in Q3 2018. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • SEI Investments held 198,139 shares of Elevance Health worth $76.6M as of Q2 2026.
  • SEI Investments sold 6,318 Elevance Health shares in Q2 2026, an estimated $2.34M.
  • Elevance Health made up 0.07% of SEI Investments's portfolio in Q2 2026, its #317 holding.
  • SEI Investments first reported a position in Elevance Health in Q4 2014 and has held it in 47 quarters since.
  • SEI Investments's Elevance Health position peaked at $124M in Q3 2018.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.